International Cannabis Weekly: 133

• Cannabis Europa Madrid launches on 10 February.
• Aurora receives permits to resume selling medical cannabis products in Germany.
• Bernie Sanders pledges to immediately legalise cannabis if elected.
• The slow pace of legislation is fuelling the black market.

With only 10 seats remaining, this is your last chance to join Europe’s premier cannabis conference, bringing you thought-provoking panels, unparalleled access to industry leaders and unrivalled networking opportunities.

The countdown has begun.

Book tickets

• French pilot programme could begin in September, according to the ANSM.
• The European Cannabis Observatory asks Spain to publicise cannabis licensing system.
• Second cannabis fund launches in London.
• What to know about Cannabis Europa Madrid 2020.
• Spanish cannabis activists expect progression on medical cannabis policies.
• Hundreds of German cannabis activists protest for comprehensive cannabis reform.
• Families of British patients criticise the NHS over ‘failing to prescribe medical cannabis’.
• Tilray stock gains 5.5% after Tilray Portugal receives second GMP certification.

• Aurora CEO resigns as the company cuts 500 jobs.
• Illinois dispensaries sell US$40 million worth of cannabis within first month of legal sales.
• Struggling US cannabis companies look to Canada for bankruptcy protection.
• Avicanna ranks highest for SAM corporate sustainability assessment.
• Michigan reports US$18 million in cannabis sales, two months on from legalisation.
• US government believes the upcoming UN vote may boost cannabis legalisation efforts.

• Australia holds public consultation on proposed medical cannabis production licence.
• Australia expedites review of Epidiolex.
• Lawmakers in the Philippines discuss multiple medical cannabis bills.
• Malaysian health minister says that drugs will be decriminalised during first term in office.

• Trinidad and Tobago asks stakeholders to comment on its new cannabis bill.
• Colombian cannabis exports remain on hold.
• The Bahamas will review adult-use plans after years of decriminalisation.

• Israel’s Ministry of Health reveals updated medical cannabis patient numbers.
• Tanzanian lawmakers debate legalising cannabis production.
• South Africa’s Minister of Finance is growing cannabis at home.
• Lesotho cannabis company selected to supply Europe’s largest medical cannabis study.

• Scientists discover THC forms a complex with vitamin E acetate in vape e-liquids.
• Cannabis & cannabinoids show promise in alleviating symptoms of rheumatic diseases.
• Nearly one-quarter of outpatient palliative care patients report using THC and CBD.
• Why Cannabigerol is so expensive to produce.

• Psilocybin and other natural psychedelics decriminalised in Santa Cruz, California.
• New study finds psilocybin-assisted psychotherapy can deliver benefits long-term.
• A study has reviewed the effects of emotional wellbeing on psychedelic use outcomes.
• Natural psychedelic use linked to a reduction in cannabis, opioid and stimulant misuse.

Advanced research, clinical trials and passionate campaigning from patient advocates has helped to progress legislation across the globe. Despite this, patients are seemingly continuing to turn to unregulated, black market suppliers to get their medicine.
What does this tell us about the state of medical cannabis?

Read now

CBD cosmetics are turning heads inside the beauty industry, becoming the most disruptive force in the industry in the last two decades. The skyrocketing demand for CBD beauty products is bolstering a market predicted to be worth US$959 million by 2024.

Learn more about the impact CBD is having on the beauty industry in our executive summary of The Impact Series: Disrupting Beauty.

Read now